During pregnancy, every expectant parent certainly wants to ensure their baby grows healthily from the womb. One important step to support this is by undergoing Non-Invasive Prenatal Testing (NIPT), a recent innovation in early detection of genetic disorders in the fetus.

NIPT is a screening method that analyzes fetal DNA fragments found in the pregnant mother's blood. Through this advanced technology, NIPT can detect the risk of various chromosomal abnormalities such as trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome), trisomy 13 (Patau syndrome), as well as sex chromosome disorders (XXY, XYY, XO, XXX) without harming the fetus or mother.

Unlike invasive methods like amniocentesis, NIPT does not require amniotic fluid sampling, making it low risk and far more comfortable. This test can be performed as early as 10 weeks of pregnancy and is highly recommended for pregnant women at high risk, such as those aged ≥35, with a family history of genetic disorders, suspicious ultrasound results, or pregnancy via IVF.

PRAMITA Clinical Laboratory offers NIPT services with various panel options tailored to the needs of Sahabat PRAMITA, including:

Trisomy Screening Panel: Detects the risk of trisomy 21, 18, and 13.

Advanced Panel: Includes sex chromosome analysis and microdeletion disorders.

Comprehensive Panel: Full examination covering other structural chromosomal abnormalities.

Through NIPT, expectant parents gain not only early, accurate information but also the opportunity to prepare the best steps for fetal health. Moreover, NIPT results can serve as a guide for doctors in determining optimal prenatal care.

Sahabat PRAMITA, make pregnancy a moment of preparedness and peace of mind. Trust your NIPT examination to PRAMITA Clinical Laboratory for a healthier, well-planned future for your little one.